Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore, Nebion to Promote Each Other's Data Analysis Products

NEW YORK (GenomeWeb News) – Bioinformatics firms Qlucore and Nebion today announced a collaboration to promote each other's data analysis products.

Under the terms of the deal, they will promote Qlucore Omics Explorer and Nebion's Genevestigator. Financial and other terms were not disclosed.

Qlucore Omics Explorer is a software program for exploring and analyzing high dimensional datasets interactively and in real time. Genevestigator is a web platform that integrates expression data and curated sample annotations, enabling the "systematic screening of the database for genes that have unique expression properties and validation of target and biomarker genes by checking how they respond to thousands of experimental conditions," the partners said.

Genevestigator originated as an academic project of the Swiss Federal Institute of Technology. Zurich-based Nebion took over development of the product in 2008 and then commercialized it.

In a statement Qlucore CEO Carl-Johan Ivarsson said that "Nebion complements the Qlucore product offering perfectly by enabling a web-based systematic screening of genes across many thousand experiments, so it makes perfect sense to work together to provide a broader solution to our clients."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.